Literature DB >> 8317442

Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities.

C A Derby1, A L Hume, M M Barbour, J B McPhillips, T M Lasater, R A Carleton.   

Abstract

Correlates and prevalence of current postmenopausal estrogen use were examined in two southeastern New England communities for the period 1981 through 1990. Data were obtained from five biennial cross-sectional household health surveys, with current use of postmenopausal estrogen determined by inspection of medication bottles. Analysis included 3,279 women aged 40-64 years, of whom 2,215 (67.6%) were postmenopausal. The prevalence of estrogen use among all postmenopausal women increased from 5.3% (95% confidence interval (CI) 3.2-7.4) in 1981-1982 to 10.9% (95% CI 7.5-14.4) in 1989-1990. Among women with surgical menopause, prevalence increased from 11.4% (95% CI 6.6-16.2) to 20.3% (95% CI 13.6-27.0), while use among women with natural menopause increased from 1.5% (95% CI 0.04-2.9) to 3.5% (95% CI 0.74-6.2). Logistic regression was used to compute age-adjusted prevalence of estrogen use according to demographic characteristics and cardiovascular risk factors. Postmenopausal estrogen use was positively associated with income, and a positive trend with education was suggested. Estrogen use was positively associated with high density lipoprotein cholesterol and was inversely associated with body mass index. Nonsmokers, women who exercised at least once per week, and women who reported having their cholesterol checked in the past year were more likely to use estrogen. These findings suggest that estrogen users have a more healthy profile than do nonusers. In addition, the prevalence of postmenopausal estrogen use appears to be substantially lower in women with natural versus surgical menopause throughout the period studied.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317442     DOI: 10.1093/oxfordjournals.aje.a116616

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Mammography in New Hampshire: characteristics of the women and the exams they receive.

Authors:  P A Carney; M E Goodrich; D M O'Mahony; A N Tosteson; M S Eliassen; S P Poplack; S Birnbaum; B G Harwood; K A Burgess; B T Berube; W S Wells; J P Ball; M M Stevens
Journal:  J Community Health       Date:  2000-06

2.  Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort.

Authors:  S Mohammed-Cherif; S Briançon; G Potier de Courcy; P Preziosi; B Fieux; M Zarebska; P Galan; S Hercberg
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

Review 3.  Gonadal hormone substitutes: effects on the cardiovascular system.

Authors:  T B Clarkson; J M Cline; J K Williams; M S Anthony
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA).

Authors:  E J Jacobs; E White; N S Weiss
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

5.  Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

Authors:  M T Connelly; M Richardson; R Platt
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

6.  Ovarian aging and hormone replacement therapy. Hormonal levels, symptoms, and attitudes of African-American and white women.

Authors:  K T Pham; J A Grisso; E W Freeman
Journal:  J Gen Intern Med       Date:  1997-04       Impact factor: 5.128

7.  Reproductive factors and hormone use and risk of adult gliomas.

Authors:  Martha J Felini; Andrew F Olshan; Jane C Schroeder; Susan E Carozza; Rei Miike; Terri Rice; Margaret Wrensch
Journal:  Cancer Causes Control       Date:  2008-09-03       Impact factor: 2.506

8.  Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.

Authors:  T Lancaster; G Surman; M Lawrence; D Mant; M Vessey; M Thorogood; P Yudkin; E Daly
Journal:  J Epidemiol Community Health       Date:  1995-08       Impact factor: 3.710

9.  Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study.

Authors:  A Zeleniuch-Jacquotte; A Akhmedkhanov; I Kato; K L Koenig; R E Shore; M Y Kim; M Levitz; K R Mittal; U Raju; S Banerjee; P Toniolo
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.